Oric Pharmaceuticals CEO Jacob Chacko's 2023 pay falls 28% to $3.2M
Oric Pharmaceuticals reports 2023 executive compensation
By ExecPay News
Published: April 24, 2024
Oric Pharmaceuticals reported fiscal year 2023 executive compensation information on April 24, 2024.
In 2023, three executives at Oric Pharmaceuticals received on average a compensation package of $2M, a 25% decrease compared to previous year.
Average pay of disclosed executives at Oric Pharmaceuticals
Jacob M. Chacko, Chief Executive Officer, received $3.2M in total, which decreased by 28% compared to 2022. 57% of Chacko's compensation, or $1.8M, was in option awards. Chacko also received $350K in non-equity incentive plan, $596K in salary, $396K in stock awards, as well as $15K in other compensation.
Pratik Multani, Chief Medical Officer, received a compensation package of $1.5M, which decreased by 21% compared to previous year. 43% of the compensation package, or $651K, was in option awards.
Dominic Piscitelli, Chief Financial Officer, earned $1.4M in 2023, a 24% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 24, 2024.